Author

J. Sadoshima

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Aslan· 1 shared A. Chakraborty· 1 shared A. Selariu· 1 shared C. A. Toro· 1 shared C. Chow· 1 shared C. F. Lee· 1 shared C. Light· 1 shared C. P. Cardozo· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

A. Aslan

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Muscle-restricted Nox4 knockout partially corrects muscle contractility following spinal cord injury in mice

C. A. Toro, R. De Gasperi, A. Aslan, N. Johnson, M. M. Siddiq, C. Chow, W. Zhao, L. Harlow, Z. A. Graham, X.-H. Liu, J. Sadoshima, R. Iyengar, C. P. Cardozo

This study shows that muscle-specific Nox4 knockout in mice improves muscle contractility after spinal cord injury, though force remains lower than in uninjured controls.

bioRxiv · Aug 4, 2023 · PreprintPhysiology

New intranasal and injectable gene therapy for healthy life extension

H. Zhu, D. K. Jaijyan, A. Selariu, R. Cruz-cosme, M. Tong, S. Yang, G. Church, D. Kekich, J. Sadoshima, Q. Tang, E. Parrish

This paper demonstrates that intranasal and injectable CMV-based gene therapy can extend lifespan and improve health in mice by overexpressing TERT and FST.

bioRxiv · Jun 26, 2021Cell Biology

NAD+ Redox Imbalance in the Heart Exacerbates Diabetic Cardiomyopathy

Y. A. Chiao, A. Chakraborty, C. Light, R. Tian, J. Sadoshima, X. Shi, H. Gu, C. F. Lee

This study shows that NAD+ redox imbalance worsens diabetic cardiomyopathy by impairing cardiomyocyte function and suggests NAMPT as a therapeutic target.

bioRxiv · Jul 3, 2020Physiology